Literature DB >> 34256721

Case series of idiopathic intracranial hypertension in three patients with immune-complex glomerulonephritis.

Felix Fischbach1, Anne Deborah Scholz-Hehn2, Christian Gerloff2, Monika Pötter-Nerger2.   

Abstract

BACKGROUND: Idiopathic intracranial hypertension (IIH) is defined by an increased cerebrospinal fluid pressure in the absence of inflammation, structural obstructions, or mass lesions. Although the underlying pathogenesis of IIH is not fully understood, associations with specific risk factors as obesity, obstruction of cerebral venous sinuses, medications, endocrine or systemic conditions and chronic kidney disease have been described. Immune-complex glomerulonephritis as IgA-nephropathy is a frequent cause of chronic kidney failure, which was reported previously in one IIH patient. To date, there is no knowledge about the variable relation of immune-complex nephritis, kidney function and the course of IIH. CASE
PRESENTATION: We report three cases (two females) of concurrent diagnosis of IIH and immune-complex glomerulonephritis. All patients presented with typical IIH symptoms of headache and visual disturbances. Two patients had been diagnosed with IgA-nephropathy only few weeks prior to IIH diagnosis. The third patient had been diagnosed earlier with terminal kidney failure due to a cryoglobulin glomerulonephritis.
CONCLUSION: We propose a possible link between renal deposition of immune-complexes and increased cerebrospinal fluid pressure. Pathophysiological hypotheses and clinical implications are discussed. We recommend clinical awareness and further systematic research to obtain more information on the association of IIH and immune-complex glomerulonephritis.
© 2021. The Author(s).

Entities:  

Keywords:  Case report; Idiopathic intracranial hypertension; IgA nephropathy; Immune-complex glomerulonephritis; Nephropathy; Pseudotumor cerebri

Year:  2021        PMID: 34256721     DOI: 10.1186/s12883-021-02297-3

Source DB:  PubMed          Journal:  BMC Neurol        ISSN: 1471-2377            Impact factor:   2.474


  9 in total

1.  Deterioration of GFR in IgA nephropathy as measured by 51Cr-EDTA clearance.

Authors:  S Rekola; A Bergstrand; H Bucht
Journal:  Kidney Int       Date:  1991-12       Impact factor: 10.612

2.  Pseudotumor cerebri in children.

Authors:  P H Phillips; M X Repka; S R Lambert
Journal:  J AAPOS       Date:  1998-02       Impact factor: 1.220

Review 3.  Pediatric idiopathic intracranial hypertension (pseudotumor cerebri).

Authors:  Melissa W Ko; Grant T Liu
Journal:  Horm Res Paediatr       Date:  2010-10-21       Impact factor: 2.852

4.  Benign intracranial hypertension and chronic renal failure.

Authors:  D Chang; G Nagamoto; W E Smith
Journal:  Cleve Clin J Med       Date:  1992 Jul-Aug       Impact factor: 2.321

5.  The relationship between idiopathic intracranial hypertension and obesity.

Authors:  Jan Hannerz; Kaj Ericson
Journal:  Headache       Date:  2009-02       Impact factor: 5.887

6.  Pseudotumor cerebri with vision impairment in two children with renal transplantation.

Authors:  K J Sheth; J D Kivlin; H E Leichter; C G Pan; C Multauf
Journal:  Pediatr Nephrol       Date:  1994-02       Impact factor: 3.714

Review 7.  Cranial venous outflow obstruction and pseudotumor Cerebri syndrome.

Authors:  B K Owler; G Parker; G M Halmagyi; I H Johnston; M Besser; J D Pickard; J N Higgins
Journal:  Adv Tech Stand Neurosurg       Date:  2005

8.  IgA Nephropathy in a Patient Presenting with Pseudotumor Cerebri.

Authors:  Umair Syed Ahmed; Patrick Bacaj; Hafiz Imran Iqbal; Songul Onder
Journal:  Case Rep Nephrol       Date:  2016-02-16

Review 9.  Idiopathic intracranial hypertension: consensus guidelines on management.

Authors:  Susan P Mollan; Brendan Davies; Nick C Silver; Simon Shaw; Conor L Mallucci; Benjamin R Wakerley; Anita Krishnan; Swarupsinh V Chavda; Satheesh Ramalingam; Julie Edwards; Krystal Hemmings; Michelle Williamson; Michael A Burdon; Ghaniah Hassan-Smith; Kathleen Digre; Grant T Liu; Rigmor Højland Jensen; Alexandra J Sinclair
Journal:  J Neurol Neurosurg Psychiatry       Date:  2018-06-14       Impact factor: 10.154

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.